High Resolution Melting Analysis for JAK2 Exon 14 and Exon 12 Mutations

This publication has 25 references indexed in Scilit:

• MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients
  Blood, 2006
• Report on two novel nucleotide exchanges in the JAK2 pseudokinase domain: D620E and E627E
  Leukemia, 2006
• Combined Locked Nucleic Acid and Molecular Beacon Technologies for Sensitive Detection of the JAK2V617F Somatic Single-Base Sequence Variant
  Clinical Chemistry, 2006
• The JAK2V617F mutation is detectable at very low level in peripheral blood of healthy donors
  Leukemia, 2006
• X-inactivation–based clonality analysis and quantitative JAK2V617F assessment reveal a strong association between clonality and JAK2V617F in PV but not ET/MMM, and identifies a subset of JAK2V617F-negative ET and MMM patients with clonal hematopoiesis
  Blood, 2006
• Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders
  Blood, 2005
• The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes
  Blood, 2005
• Identification of an Acquired JAK2 Mutation in Polycythemia Vera
  Journal of Biological Chemistry, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Published by Elsevier ,2005
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005